Key result
FVII R353Q polymorphism shows no association with myocardial infarction risk.
Why the study?
Genetic components contribute to myocardial infarction development, and the association of R353Q polymorphism in the FVII gene with MI risk was suspected but unclear.
Does the R353Q (rs6046) polymorphism in the FVII gene increase the risk of myocardial infarction?
Meta-Analysis (n=10,030)
Does the R353Q (rs6046) polymorphism in the FVII gene increase the risk of myocardial infarction?
This meta-analysis demonstrates that the R353Q polymorphism in the FVII gene is not a significant genetic marker for myocardial infarction risk in the overall population, although associations may vary among specific subgroups like the Asian population.
Answers are grounded in this paper and cite their sources.
Does not support R353Q genotyping for MI risk assessment; leaves open possible subgroup effects in Asian populations.
OBJECTIVE: Genetic components substantially contribute to the development of myocardial infarction (MI), and R353Q polymorphism (rs6046) in FVII gene has been suspected to be associated with the risk of MI. METHODS: A meta-analysis was conducted on the links between R353Q polymorphism and the susceptibility of MI. A comprehensive literature search was performed on 8 electronic databases. The main effects of the genotypes were estimated using a logistic regression approach. The odds ratios with 95% confidence intervals were calculated using the conventional summary method meta-analysis. The possible sources of heterogeneity among the included studies were explored using meta-regression analysis and subgroup analysis. RESULTS: A total of 18 eligible case-control studies, comprising of 4701 cases and 5329 controls, were included. No overall statistical relationship was identified between R353Q and MI by any of the genetic models. The meta-regression demonstrated that the Asian population, body mass index (BMI) category, and diabetes affected the heterogeneity. In addition, subgroup analyses showed that heterogeneities were identified in Asian population and BMI category, which highly agree with the results of meta-regression. CONCLUSIONS: The current meta-analysis suggested that R353Q polymorphism was not associated with the MI risk. Asian population, BMI category, and diabetes might be related to the incidence of MI. However, large-scale, case-control studies with rigorous designs are essential to provide accurate evidence.
No takes yet. Share an insight, caveat, or question.
Huang et al. (2018) conducted a meta-analysis in Myocardial Infarction (n=10,030). R353Q (rs6046) polymorphism in FVII gene vs. Absence of the polymorphism (e.g., QQ genotype or Q allele) was evaluated on Risk of myocardial infarction (OR 1.03, 95% CI 0.92-1.16, p=>0.05). The R353Q polymorphism in the FVII gene was not associated with an increased risk of myocardial infarction.
Synapse has enriched 10 related papers. Consider them for comparative context: